Home

NanoViricides, Inc. Common Stock (NNVC)

1.1500
-0.0100 (-0.86%)
NYSE · Last Trade: Apr 3rd, 12:47 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Sessionbenzinga.com
Via Benzinga · June 20, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · June 20, 2024
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Via Benzinga · June 14, 2024
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · June 14, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · June 12, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · June 10, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursdayinvestorplace.com
Pre-market stock movers are worth checking out on Thursday morning as we dive into all of the hottest news affecting shares this morning!
Via InvestorPlace · June 6, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · June 5, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · June 4, 2024
12 Health Care Stocks Moving In Monday's After-Market Sessionbenzinga.com
Via Benzinga · June 3, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · May 16, 2024
NNVC Stock Earnings: Nanoviricides Beats EPS for Q3 2024investorplace.com
NNVC stock results show that Nanoviricides beat analyst estimates for earnings per share the third quarter of 2024.
Via InvestorPlace · May 15, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · May 6, 2024
3 Nanotech Stocks With the Potential to Make You an Overnight Millionaireinvestorplace.com
Discover three nanotech stocks poised for explosive growth in a booming market. Explore their potential for massive returns.
Via InvestorPlace · May 2, 2024
A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?benzinga.com
Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is.
Via Benzinga · January 31, 2024
NanoViricides, Inc. (NNVC) To Unveil Cutting-Edge Antiviral Breakthroughs At Biotech Showcase™ 2024benzinga.com
NanoViricides, Inc. (NYSE American: NNVC) recently announced that it is presenting at Biotech Showcase™ 2024. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco
Via Benzinga · January 8, 2024
Is This Ticker That InvestorsObserver Expects To Soar By More Than 350% Next Year On Your Watchlist?
--News Direct--
Via News Direct · December 1, 2023
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrantbenzinga.com
Read the latest report on NanoViricides here
Via Benzinga · October 2, 2023
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrantbenzinga.com
Read the latest report on NanoViricides here
Via Benzinga · September 26, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · August 22, 2023
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?benzinga.com
Read the latest report on NanoViricides here.
Via Benzinga · July 18, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · July 11, 2023
Why Are NanoViricides Shares Gaining Todaybenzinga.com
NanoViricides Inc (NYSE: NNVC) shares are trading higher after the company reported preclinical data from an antiviral clinical drug candidate for 
Via Benzinga · July 11, 2023
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Novel Nanomedicine Platform With Pipeline Of Antivirals Goes To Human Trials – What Other Viruses Could This COVID Treatment Target?
Via News Direct · July 11, 2023
Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarketbenzinga.com
Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.
Via Benzinga · July 11, 2023